ADMA Biologics, Inc. (ADMA)
19.54
+0.05
(+0.26%)
USD |
NASDAQ |
Dec 24, 16:00
ADMA Biologics Market Cap: 4.650B for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.715B |
| Vanda Pharmaceuticals, Inc. | 408.36M |
| Aldeyra Therapeutics, Inc. | 317.66M |
| Arcutis Biotherapeutics, Inc. | 3.607B |
| Exelixis, Inc. | 12.47B |
Market Cap Related Metrics
| PE Ratio | 22.95 |
| PS Ratio | 9.837 |
| PEG Ratio | 0.1102 |
| Price to Book Value | 10.79 |
| Price to Free Cash Flow | 118.35 |
| Price | 19.54 |
| Earnings Yield | 4.36% |
| PEGY Ratio | 0.1102 |
| Operating PE Ratio | 28.78 |
| Normalized PE Ratio | 22.60 |